QNTM Stock Analysis: Buy, Sell, or Hold?
QNTM - Quantum Biopharma Ltd. Class B Subordinate Voting Shares
$4.08
0.23 (6.02%)
▲
5d:
+12.13%
30d:
-55.83%
90d:
-13.71%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When QNTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: QNTM shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: QNTM shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: QNTM is currently trading at $4.08, which is considered slightly low relative to its 30-day fair value range of $3.60 to $6.94.
Technical Outlook: Technically, QNTM is in a uptrend. Immediate support is located at $3.59, while resistance sits at $7.83. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: QNTM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.30 (+219.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, QNTM is in a uptrend. Immediate support is located at $3.59, while resistance sits at $7.83. The stock is showing strong short-term momentum, up 6.0% recently.
Market Sentiment: QNTM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.30 (+219.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.60 -
$6.94
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.0%)
- BULLISH: Trading 219.5% below Wall St target ($12.30)
Trading Range Analysis
30-Day Trading Range
$3.60 -
$6.94
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.59
Resistance Level
$7.83
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$12.30
(+219.5%)
Share & Embed Analysis
Last updated: June 24, 2026 11:10 AM ET
Data refreshes hourly during market hours. Next update: 12:10 PM
Data refreshes hourly during market hours. Next update: 12:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QNTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 54 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 67 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |